OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells
Pengfei Zhang, Xu Pei, Kesang Li, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

The emerging roles of circRNAs in cancer and oncology
Lasse S. Kristensen, Theresa Jakobsen, Henrik Hager, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 3, pp. 188-206
Closed Access | Times Cited: 792

CircRNA in cancer: Fundamental mechanism and clinical potential
Liang Chen, Ge Shan
Cancer Letters (2021) Vol. 505, pp. 49-57
Closed Access | Times Cited: 351

Review on circular RNAs and new insights into their roles in cancer
Xiaozhu Tang, Hongyan Ren, Mengjie Guo, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 910-928
Open Access | Times Cited: 269

The role of cancer-derived microRNAs in cancer immune escape
Ming Yi, Linping Xu, Ying Jiao, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 176

Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance
Chaochu Cui, Jianbo Yang, Li Xiao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 164

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
Wenxiao Jiang, Shuya Pan, Xin Chen, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 120

Going circular: history, present, and future of circRNAs in cancer
Giuseppina Pisignano, David C. Michael, Tanvi H. Visal, et al.
Oncogene (2023) Vol. 42, Iss. 38, pp. 2783-2800
Open Access | Times Cited: 99

CircGPR137B/miR-4739/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma
Lianyong Liu, Mingjun Gu, Junhua Ma, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 98

Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 80

Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 218-218
Open Access | Times Cited: 72

Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
Adnin Ashrafi, Zakia Akter, Pouya Modareszadeh, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4562-4562
Open Access | Times Cited: 70

Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 56

HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway
Jiancheng Lv, Kai Li, Hao Yu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 54

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32

CircRNAs in lung cancer - Biogenesis, function and clinical implication
Chengdi Wang, Shuangyan Tan, Jingwei Li, et al.
Cancer Letters (2020) Vol. 492, pp. 106-115
Open Access | Times Cited: 122

CircRNAs in anticancer drug resistance: recent advances and future potential
Tianwei Xu, Mengwei Wang, Lihua Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 92

CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing
Peng Shen, Taoyue Yang, Qun Chen, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 90

circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling
Jingpeng Liu, Xiao Jiang, Ailing Zou, et al.
Cancer Research (2020) Vol. 81, Iss. 2, pp. 344-355
Open Access | Times Cited: 84

Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer
Ying Liu, Xiang Ao, Wanpeng Yu, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 27, pp. 50-72
Open Access | Times Cited: 68

Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
Asal Jalal Abadi, Ali Zarrabi, Mohammad Gholami, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 304-304
Open Access | Times Cited: 62

Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy
Dong Yu, Qian Gao, Yong Chen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39

FGFR families: biological functions and therapeutic interventions in tumors
Qing Liu, Jiyu Huang, Weiwei Yan, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 35

Page 1 - Next Page

Scroll to top